Ranbaxy gets Japanese nod for blood pressure drug
April 8th, 2008 - 4:15 pm ICT by admin
-
Mumbai, April 8 (IANS) The Japanese ministry of health and labour welfare (MHLW) has granted marketing approval to Indian pharma major Ranbaxy Laboratories Ltd’s generic drug prescribed for treatment of blood pressure and angina. The company said Tuesday that MHLW’s authorisation for Ranbaxy’s generic Amlodipine 2.5 mg and 5 mg tablets make the hypertensive medicine the first of its kind to be developed by a generic pharmaceutical company outside Japan.
According to Intercontinental Marketing Services (IMS), the world’s leading health services data provider, Amlopidine has a market size of $2 billion in Japan.
Since 2004, Ranbaxy had filed seven products in Japan and till date has managed to achieve approval for every filing, the company said. The firm had made forays into the Japanese market in 2002 through a strategic alliance with mid-sized research pharma company, Nippon Chemiphar Ltd (NC) of Japan.
Sphere: Related ContentRelated Stories
- Lupin gets green signal for 10 drugs in Japan - Apr 23, 2008
- Wockardt gets US nod for Tamsulosin capsules - Sep 29, 2009
- US chip maker to set up lab in Bhubaneswar (Business Capsule-Two) - Sep 18, 2009
- Ranbaxy gets USFDAs permission to manufacture cardiovascular drugs - Mar 09, 2009
- Gilead's model to enhance availability of anti-AIDS drug - Feb 22, 2009
- Sun Pharma gets US nod for women's drug - Sep 12, 2008
- Ranbaxy subsidiary wins fraud case in UK - Jul 22, 2008
- Ranbaxy denies US allegation, says Daiichi deal on track - Jul 14, 2008
- Daiichi, Ranbaxy to cooperate with US drug regulator as Indian firm faces charge (Lead) - Feb 26, 2009
- US drug regulator says Ranbaxy forged data, test results - Feb 26, 2009
- Business
- amlodipine
- amlopidine
- authorisation
- blood pressure drug
- data provider
- forays
- generic drug
- intercontinental marketing
- japanese market
- japanese ministry
- labour welfare
- leading health
- marketing services
- mg tablets
- mhlw
- ministry of health
- nippon
- pharmaceutical company
- ranbaxy laboratories ltd
- strategic alliance
Posted in Business, |